Experience

AMYRA Biotech AG

• Switzerland
• Biotechnology Research
• 1 - 100 Employee

• Head Of Product Development

  • Mar 2022 - Present

  AMYRA is developing safe and effective therapeutics for the prevention of gluten-related health disorders. AMYRA is developing safe and effective therapeutics for the prevention of gluten-related health disorders.



CanVirex

• Switzerland
• Biotechnology Research
• 1 - 100 Employee

• Consultant

  • Nov 2022 - Present

  CanVirex is a spin-off from the Heidelberg University Hospital, founded in 2017 in Basel, Switzerland. The company develops novel immunotherapeutics for the treatment of cancer. CanVirex and Heidelberg University Hospital have signed a strategic collaboration agreement for the research and clinical development of measles-vectored therapeutics. The Heidelberg University Hospital offers a unique infrastructure for swift clinical translation of our most promising drug candidates. CanVirex is a spin-off from the Heidelberg University Hospital, founded in 2017 in Basel, Switzerland. The company develops novel immunotherapeutics for the treatment of cancer. CanVirex and Heidelberg University Hospital have signed a strategic collaboration agreement for the research and clinical development of measles-vectored therapeutics. The Heidelberg University Hospital offers a unique infrastructure for swift clinical translation of our most promising drug candidates.